Gain Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

77.63M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	55.18K	-84.93K	-60.62%
Dec 31, 2022	140.11K	-24.89K	-15.08%
Dec 31, 2021	164.99K	136.11K	471.29%
Dec 31, 2020	28.88K	-12.42K	-30.07%
Dec 31, 2019	41.30K	20.69K	100.40%
Dec 31, 2018	20.61K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company Name	Revenue
Spero Therapeutics	61.19M
Champions Oncology	59.43M
Atara Biotherapeutics	23.14M
Alterity Therapeutics	4.43M
Inovio Pharmaceuticals	65.34K

Revenue Rankings

GANX News

22 days ago - Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update - GlobeNewsWire
5 weeks ago - Gain Therapeutics receives FDA clearance of GT-02287 IND application - TheFly
5 weeks ago - Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson's Disease - GlobeNewsWire
7 weeks ago - Gain Therapeutics Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference - Transcripts
2 months ago - Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit - GlobeNewsWire
2 months ago - Gain Therapeutics Slides: Corporate presentation - Filings
2 months ago - Gain Therapeutics presents data from Phase 1b study of GT-02287 - TheFly
2 months ago - Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026 - GlobeNewsWire

More News